Further, CXCR4-YY1 reciprocal regulation has been well documented as a pro-tumorigenic function of CXCR4 in AML therapy resistance and osteosarcoma angiogenesis47,51. This evidence concerns the gene CXCR4 and acute myeloid leukemia.